vTv Therapeutics Inc.
VTVT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641489
No open-market purchases or sales by vTv Therapeutics Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $60.5M in total; no superinvestor holds it.
Holders of 5% or more of VTVT
Holders whose latest Schedule 13D or 13G filing reports 5% or more of vTv Therapeutics Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Samsara BioCapital, L.P. | 13D/A | 9.90%403.9K shares | 0.00 ppfrom 9.90% | Mar 5, 20244 filings | Dec 9, 2025 | SEC |
| Trails Edge Capital Partners, LP | 13G | 9.90%340.5K shares | New | Sep 8, 20251 filing | Sep 8, 2025 | SEC |
| Invus Global Management, LLC | 13G/A | 9.40%393.1K shares | −0.59 ppfrom 9.99% | Sep 8, 20252 filings | Nov 12, 2025 | SEC |
| Millennium Management LLC | 13G/A | 6.90%269.9K shares | +1.20 ppfrom 5.70% | Mar 27, 20263 filings | Jul 29, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
18 Schedule 13D and 13G filings on vTv Therapeutics Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jul 29, 20266:45 PM ET | Millennium Management LLCand 3 others | 13G/A | 6.90%269.9K shares | +1.20 ppfrom 5.70% | Jun 30, 2026 | SEC |
| Apr 16, 20265:15 PM ET | Millennium Management LLCand 3 others | 13G/A | 5.70%225.1K shares | +0.70 ppfrom 5.00% | Apr 13, 2026 | SEC |
| Mar 27, 20264:45 PM ET | Millennium Management LLCand 2 others | 13G | 5.00%198.2K shares | New | Mar 24, 2026 | SEC |
| Dec 9, 20254:17 PM ET | Samsara BioCapital, L.P.and 4 others | 13D/A | 9.90%403.9K shares | 0.00 ppfrom 9.90% | Dec 8, 2025 | SEC |
| Nov 12, 202510:29 AM ET | Invus Global Management, LLCand 7 others | 13G/A | 9.40%393.1K shares | −0.59 ppfrom 9.99% | Sep 30, 2025 | SEC |
| Sep 25, 20255:06 PM ET | Samsara BioCapital, L.P.and 4 others | 13D/A | 9.90%343.2K shares | 0.00 ppfrom 9.90% | Sep 22, 2025 | SEC |
| Sep 8, 20256:00 PM ET | Trails Edge Capital Partners, LPand 2 others | 13G | 9.90%340.5K shares | New | Aug 29, 2025 | SEC |
| Sep 8, 20255:43 PM ET | Invus Global Management, LLCand 7 others | 13G | 9.99%348.1K shares | New | Aug 29, 2025 | SEC |
| Sep 3, 20257:33 PM ET | Samsara BioCapital, L.P.and 2 others | 13D/A | 9.90%343.2K shares | – | Aug 29, 2025 | SEC |
| Nov 12, 2024 | FMR LLC | 13GOld format | – | New | – | SEC |
| Mar 22, 2024 | MacAndrews & Forbes Inc. | 13D/AOld format | – | – | – | SEC |
| Mar 5, 2024 | Samsara BioCapital, L.P. | 13DOld format | – | New | – | SEC |
| Mar 5, 2024 | Baker Bros. Advisors LP | 13DOld format | – | New | – | SEC |
| Aug 23, 2022 | Medpace Investors, LLC | 13GOld format | – | New | – | SEC |
| Jun 10, 2022 | G42 Investments AI Holdings RSC Ltd. | 13DOld format | – | New | – | SEC |
| Jun 1, 2022 | MacAndrews & Forbes Inc. | 13D/AOld format | – | – | – | SEC |
| Nov 12, 2021 | MacAndrews & Forbes Inc. | 13D/AOld format | – | – | – | SEC |
| Sep 17, 2021 | MacAndrews & Forbes Inc. | 13D/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell vTv Therapeutics Inc. shares.
No Form 144 notices for vTv Therapeutics Inc. are on file.